Medidata Solutions
announced that South Korean contract research organization (CRO)
MediCROstar
has joined Medidata’s channel partner program for CROs and other service providers. In addition to bringing the capabilities of the
Medidata Rave
electronic data capture (EDC) and clinical data management (CDM) solution, the partnership will enable MediCROstar to further expand its presence in the APAC region and continue to build its stake in the global clinical trials marketplace.
Founded in 2006, Seoul-based MediCROstar specializes in electronic case report format (eCRF) data management and protocol development for investigator-initiated trials. With experience managing clinical trials across South Korea and India, MediCROstar executives helped the Korea Food and Drug Administration (KFDA) write formal guidance on conducting EDC trials. As a result, the company has become a player in South Korea’s clinical development as the growth in clinical trials in the region has driven increasing need for technologies as well as outsourcing organizations to help efficiently manage the studies. MediCROstar looks to the Medidata partner program as a key driver of its global expansion and is developing new services around Medidata Rave to offer customers the efficient data management, local language capabilities and ease of use of the proven Rave platform.
“The adoption of EDC technology is a growing trend in South Korea, mirroring its use in the global pharmaceutical industry, and we have looked to Medidata’s partner program to help us field the increasing demand for innovative clinical technologies,” said Inyoung Choi, director, MediCROstar.
MediCROstar expects to leverage the Medidata Rave solution for a number of Phase III global multinational trials over the next year.
On September 10th, Medidata and MediCROstar will co-host a seminar titled “Safe Transfer – From Paper CRF to eCRF” at EL Tower, 24 Yangjae-dong, Seocho-gu, Seoul, South Korea. The seminar will outline the sponsor and CRO benefits of the Medidata Rave solution and introduce trends of data management in Korea. Presenters include Dong-Seok Yim, MediCROstar CEO, and Takeru Yamamoto, head of APAC at Medidata Solutions. For more information, please visit:
www.medicrostar.com
Medidata first announced its channel partner program in April 2005 to enable select CROs and other service providers to offer Medidata Rave implementation services. Since then, the program has grown to include over 25 partners. For more information, please visit:
www.mdsol.com/partnerships/cros.htm
.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.